Controllable pH-responsive hollow dendritic mesoporous bioactive glass nanocarriers for sustained doxorubicin release

Key Points

• Doxorubicin release demonstrates control through pH changes, highlighting its effectiveness.
• Key evidence includes sustained release profiles observed over 72 hours in simulated environments.
• Analysis of hollow dendritic mesoporous bioactive glass nanocarriers illustrates their potential in drug delivery.
• This technology may enhance treatment options for cancer, warranting further investigation into clinical applications.